← Toutes les offres
N

Autoinjectors won't save lives in LMICs

NickLaing

Global
Publié le 16 novembre 2026

Description du poste

TLDR: Autoinjectors don't solve the real bottlenecks to getting more livesaving tranexamic acid and antivenom to patients in LMICs. Akhil and Georgia wrote a compelling article about autoinjectors in the great new InDevelopment magazine. However, they miss or understate important reasons why autoinjectors won't solve the real bottlenecks that stop lifesaving drugs getting to patients in LMICs. I thought this was an important critique to put out there, as there are many cool candidates for Advance market commitments, perhaps more money soon to fund them, and we should choose wisely. I like AMCs for new technology. They’ve made a huge impact in the past, and will in future. I love the work Akhil and crew are doing on the neonatal sepsis test AMC - if this test came to fruition, it could change the face of neonatal care. I just don’t see a clear pathway for autoinjectors saving lives in LMICs, and can’t see a strong case for AMCs for their case studies of Tranexamic Acid (TXA) and antivenom at least. The authors outline the problem well. Far more people need to get TXA and antivenom, far faster. Both interventions deserve more research and work. But I think the authors misdiagnose why health workers don’t give these drugs fast enough. Why don't we give enough tranexamic acid?The main reasons women don’t get TXA for Post-Partum Hemorrhage are that the medication often isn’t available at health facilities, and that midwives are still learning to give TXA as part of newish protocols. The problem isn’t that IV administration causes long delays. TXA is still a newish PPH treatment - it was recommended by WHO in 2017, but countries are still concerned about product quality, as there remain no WHO pre-qualified providers. Countries have only recently added TXA to their national guidelines. 1. We can’t yet give TXA into the muscle (IM)The authors’ statement “TXA does not have to be delivered by IV” is incorrect and could be dangerous.[1] The WHO recommends giving TXA IV. We